News from bd (becton, dickinson and company) A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Oct 22, 2020, 06:57 ET BD Announces Executive Leadership Appointments

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Patrick Kaltenbach as ...


Oct 21, 2020, 02:00 ET CerTest Biotec and BD Announce CE Mark for Combination COVID-19, Influenza, RSV Test on BD MAX™ Molecular Diagnostic System

CerTest Biotec, along with BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that the...


Oct 07, 2020, 06:55 ET BD marks 25 years with Mercy Ships: Donates $1M to support launch of world's largest NGO hospital ship

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, this year celebrates its 25 year of philanthropic...


Oct 05, 2020, 06:52 ET BD Granted FDA 510(k) Clearance for BD FACSLyric™ Flow Cytometer with Newly Integrated BD FACSDuet™ Sample Preparation System

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced it has received 510(k) clearance from...


Oct 02, 2020, 16:10 ET BD Announces Live Webcast Of Fourth Fiscal Quarter Earnings Conference Call

BD (Becton, Dickinson and Company) (NYSE:BDX) announced today that it will conduct a live webcast of its fourth fiscal quarter and full fiscal year...


Sep 30, 2020, 03:00 ET BD Announces CE Mark of Portable, Rapid Point-of-Care Antigen Test to Detect SARS-CoV-2 in 15 minutes

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its rapid, point-of-care, SARS-CoV-2...


Sep 23, 2020, 06:59 ET BD Submits Pre-Market Approval Supplement to FDA to Enable ThinPrep® Pap Test™ PreservCyt® Solution to be Used with the BD Onclarity™ HPV Assay

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it has submitted a pre-market...


Sep 21, 2020, 06:59 ET BD Announces FDA Classifications for August 4th Recalls of BD Alaris™ System Hardware for Keypads, Incorrect Module Types and/or Sizes, and Channel Error

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on previously announced...


Sep 09, 2020, 06:59 ET New Head-to-Head Study Demonstrates Equivalency and Accuracy of COVID-19 Rapid Point-of-Care Tests, Despite Different Test Sensitivity Claims

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the results of a new research study that ...


Aug 31, 2020, 17:06 ET BD to Present at Investor Healthcare Conferences

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the following...


Aug 20, 2020, 16:01 ET BD Provides Update on Previously Disclosed Recall of BD Alaris System Hardware

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today provided an update on a previously announced...


Aug 17, 2020, 16:01 ET Kristen Stewart to Join BD as Senior Vice President of Strategy and Investor Relations

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today the appointment of Kristen Stewart to...


Aug 13, 2020, 08:57 ET BD to Present at UBS Genomics 2.0 and MedTech Innovations Virtual Summit

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the UBS Genomics...


Aug 10, 2020, 06:58 ET BD and BD Foundation commit $7.8 million to helping community health centers expand innovative care to patients

BD (NYSE: BDX), a leading global medical technology company, together with the BD Foundation, its charitable affiliate, today committed $7.8 million...


Aug 07, 2020, 14:48 ET BD anuncia retiro voluntario del aplicador ChloraPrep™ 3 mL en determinados territorios estadounidenses y países

BD (Becton, Dickinson and Company), una empresa global líder que se especializa en tecnología médica, anunció el retiro voluntario del mercado el 23...


Aug 07, 2020, 06:59 ET BD Announces Voluntary Recall of ChloraPrep™ 3 mL Applicator in Specific U.S. Territories and Countries

BD (Becton, Dickinson and Company), a leading global medical technology company, announced a voluntary recall on June 23, 2020 for specified catalog...


Aug 07, 2020, 06:59 ET BD Announces Voluntary Recall of ChloraPrep™ 3 mL Applicator in Specific U.S. Territories and Countries

BD (Becton, Dickinson and Company), a leading global medical technology company, announced a voluntary recall on June 23, 2020 for specified catalog...


Aug 06, 2020, 06:00 ET BD Announces Results For 2020 Third Fiscal Quarter; Provides Fiscal 2020 Guidance

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $3.855 billion for...


Aug 03, 2020, 06:58 ET BD releases FY 2019 Sustainability Report

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today issued its 2019 Sustainability Report, focusing on ...


Jul 30, 2020, 17:13 ET BD Announces $24 Million U.S. Government Investment to Support Scale Up of U.S. Manufacturing of COVID-19 Diagnosic Tests

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced a $24 million investment from the U.S....


Jul 27, 2020, 16:10 ET BD Board Declares Dividends

The Board of Directors of BD (Becton, Dickinson and Company) (NYSE: BDX) has declared a quarterly dividend of $0.79 per common share, payable on...


Jul 22, 2020, 06:59 ET BD receives FDA Approval for HPV Test with Extended Genotyping Capabilities

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it received approval for a...


Jul 21, 2020, 06:59 ET BD Receives Additional Orders For 177 Million Injection Devices For U.S., Canada COVID-19 Vaccine Preparations

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced additional pandemic orders for needles...


Jul 15, 2020, 06:59 ET BD Supports U.S. Government Efforts to Increase COVID-19 Testing Capacity with Point-of-Care Tests

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today a commitment from the U.S. Department of ...


Jul 08, 2020, 06:59 ET BD Partners with U.S. Government on $70 Million Manufacturing Infrastructure Project for Mass Vaccination Campaigns

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the formation of a strategic,...